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Sensory abnormalities in individuals with autism spectrum disorders (ASD) has been widely 43 
noted clinically, with pain insensitivity as a specified diagnostic criterion.  However, they 44 
remain understudied and poorly understood.  Limited research has been conducted using 45 
psychophysically robust techniques, which can determine the functioning of mechanisms 46 
proposed to underlie the reported pain insensitivity.  The present study investigated 47 
somatosensory detection across mechanical and thermal sensory modalities to threshold and 48 
supra-threshold- painful –stimulation in 13 adults with ASD and 13 matched controls using 49 
the German Neuropathic Pain Network’s (DNFS) Quantitative Sensory Testing (QST) 50 
battery.  This was further supplemented with measures of pain tolerance and central 51 
modulation.  Differences between groups were observed for light touch detection and 52 
mechanical pain sensitivity with the ASD group showing higher thresholds compared to 53 
controls.  Notably, participants in the ASD group had a greater variety of response with more 54 
scores falling outside of the 95% confidence interval range.  Two participants with ASD 55 
showed dynamic mechanical allodynia and one showed paradoxical heat sensation, 56 
phenomena not typically seen in the general population or in controls.  These data support the 57 
need for more research examining central mechanisms for pain processing in ASD as well as 58 








In addition to the most striking lifelong effects of impaired communication, 65 
socialization and restrictive/repetitive behaviours in autism spectrum disorder (ASD), there is 66 
a high prevalence of sensory perceptual anomalies (Baranek, 2002).  Evidence for which has 67 
relied on autobiographical, observational or behavioural measures (Moore, 2015) which has 68 
demonstrated, amongst an array of sensory disturbances, an absence of typical pain 69 
behaviours (e.g. absence of hand withdrawal reflex or a lack of protective body positioning) 70 
when encountering pain (Bursch, Ingman, Vitti, Hyman, & Zeltzer, 2004; Gillberg & 71 
Coleman, 2000; Mahler, 1952; Rothenberg, 1960; Wing, 1996).  There is further evidence 72 
that autistic individuals have aversions to touch (Grandin, 1992, 1995; Williams, 2015), 73 
suggesting that light tactile sensation might be a source of discomfort, indicating a potential 74 
hypersensitivity to tactile stimuli (Kaiser et al., 2016; Moore, 2015).  However, such methods 75 
are typically not generalizable because it is unclear whether the case investigated is 76 
representative of the wider body of "similar" instances.  Further validation of this 77 
phenomenon is given by the re-incorporation of sensory responses as a feature in diagnostic 78 
texts suggesting that it is a central clinical finding in autism (APA, 2013).  There is however, 79 
a dearth of rigorous psychophysical experimental evidence to support these claims.  80 
Therefore, the current study aims to clarify the characteristics of pain sensitivity associated 81 
with ASD using a psychophysically robust experimental case-control design.  82 
Pain is multifaceted, defined as a distressing experience associated with actual or 83 
potential tissue damage; with sensory, emotional, cognitive and social components (IASP, 84 
2012; Williams & Craig, 2016).  Together, the percept, and the subjective reaction act as a 85 
warning system so that individuals learn to avoid dangerous stimuli (Yasuda et al., 2016), 86 
whilst also promoting behavioural analgesia (Eccleston & Crombez, 1999).  A disruption to 87 
this system could result in a lack of these learned behaviours. 88 
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Potentially nociceptive (painful) stimuli are detected by specific somatosensory 89 
receptor neurons (nerve fibres), known as nociceptors which can be classified into three 90 
different types: Aβ, Aδ and C-fibre (Besson, 1999; Delmas, Hao, & Rodat-Despoix, 2011; 91 
Djouhri & Lawson, 2004; Lumpkin & Caterina, 2007).  Nociceptive messages are typically 92 
mediated by Aδ, and C-fibres, the functionality of which, in neurotypical populations, has 93 
been well described (for reviews see Basbaum, Bautista, Scherrer, & Julius, 2009; Basbaum 94 
& Jessell, 2000; McGlone & Reilly, 2010; Meyer, Ringkamp, Campbell, & Raja, 2008).  95 
Before these signals generate a perception of ‘pain’ they are centrally integrated in the dorsal 96 
horn of the spinal cord and transmitted to the brain via the spinothalamic tract (Basbaum & 97 
Jessell, 2000; Iggo, 1977; Nafe, 1934; Schiller, 1956).  The final process in the pain 98 
experience is the social communication of pain which can be observed in stereotyped pain 99 
behaviours (Craig, 2015) and self-report – and which is neither simply, nor directly, 100 
associated with the level of nociceptor activity; nociceptor activity can produce more or less 101 
pain depending on a range of factors (Loeser, 2012).  De-coding whether these underlying 102 
mechanisms are altered in autistic individuals will give insight into the pain behaviours 103 
observed in this population.  104 
Recently a few studies have begun to disentangle the underlying sensory mechanisms 105 
of somatosensory dysfunctions in ASD using psychophysical methods, the earliest of which 106 
focused on tactile sensitivity, investigating this with vibrotactile stimuli (Blakemore et al., 107 
2006; Cascio et al., 2008; Guclu, Tanidir, Mukaddes, & Unal, 2007).  Blakemore et al. (2006) 108 
reported a frequency dependent hypersensitivity in adults with Asperger’s compared to 109 
neurotypical controls.  Conversely, Guclu et al. (2007) and Cascio et al. (2008) report no 110 
significant difference between the vibrotactile thresholds of children and adults with ASD 111 
and controls, suggesting that effects may be a result of specific frequencies, sites or other 112 
methodological differences.   113 
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Regarding pain perception, the focus has generally been towards thermal testing, with 114 
similarly mixed findings.  Thermal pain hypersensitivity but normal thermal detection has 115 
been reported in adults with ASD (Cascio et al., 2008).  Adolescents are reported to have the 116 
inverse results; normal thermal pain thresholds, but a hyposensitivity to innocuous thermal 117 
stimuli (Duerden et al., 2015).  No differences in thermal detection thresholds and electrical 118 
pain were observed by Yasuda et al. (2016) and Bird et al. (2010), however, pressure pain 119 
thresholds were lower in autistic individuals compared to controls (Fan, Chen, Chen, Decety, 120 
& Cheng, 2014).  This pattern of findings suggests no systematic change in psychophysically 121 
determined pain thresholds for autistic individuals compared to controls.  This is not to 122 
suggest that pain response in ASD is typical, both Fründt et al. (2017) and Duerden et al. 123 
(2015) report paradoxical heat sensations, a phenomenon where gentle cooling is perceived 124 
as hot or burning (Magerl & Klein, 2006), in several of their autistic participants.  This 125 
phenomenon usually does not occur in healthy individuals.   126 
Considering the paucity of evidence paired with the mixed results, probably due to the 127 
heterogeneity of participants (e.g. autism symptom severity or comorbidities) and differences 128 
regarding methods and sub-modalities investigated, the disentanglement of the underlying 129 
mechanisms of somatosensory dysfunctions in ASD is limited and there is no gold standard 130 
on how these features should be assessed in ASD.   131 
Several recent investigations (Blakemore et al., 2006; Cascio et al., 2008; Duerden et 132 
al., 2015) have utilised methodologies that have been collated into the standardised 133 
Quantitative Sensory Testing battery developed by The German Research Network on 134 
Neuropathic Pain (DFNS; Rolke et al., 2006).  This method allows for the quantification of 135 
clinically significant perception and pain thresholds (Werner, Petersen, & Bischoff, 2013) 136 
assessing the function of small and large diameter nerve fibres (Hansson, Backonja, & 137 
Bouhassira, 2007).  If used in its entirety this method allows researchers to assess nerve 138 
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function across the full range of modalities; vibration, pressure, thermal, and mechanical 139 
(Moloney, Hall, & Doody, 2012) in a standardised manner.  The focus on a single or a 140 
limited number of these sub-modalities limits previous studies.  One study, however, has 141 
utilised this full battery, therefore, providing the most comprehensive assessment of 142 
somatosensory function in ASD to date (Fründt et al., 2017).  More extreme somatosensory 143 
responses (i.e. hyper- or hypo-sensitivity) or somatosensory phenomena not typically 144 
observed in those without neuropathy (i.e. dynamic mechanical allodynia or paradoxical heat 145 
sensations) were observed in the ASD group, however, there were no group differences 146 
reported for global or systemic changes in somatosensory function. 147 
This study will similarly employ the standardised battery, conducting an independent 148 
replication of Fründt et al. (2017) and utilise the published normative reference values (Rolke 149 
et al., 2006) as they provide a determinant of sensory loss and gain that supersedes the 150 
standard group differences analysis - meaning clinically significant sensitivities in ASD can 151 
be determined.  Furthermore, this battery was extended to include a measure of pain tolerance 152 
and central pain processes, utilising the cold pressor test (von Baeyer, Piira, Chambers, 153 
Trapanotto, & Zeltzer, 2005) and Conditioned Pain Modulation (CPM; Yarnitsky et al., 154 
2015), respectively.  Including tolerance allows a wider range of psychophysics to be 155 
measured; threshold (the minimum intensity of a stimulus that is perceived as painful), 156 
suprathreshold (increases the frequency of nociceptive messages) to tolerance (the maximum 157 
intensity of a pain-producing stimulus that a subject is willing to accept in a given situation 158 
(Chapman et al., 1985; IASP, 2012).  Tolerance also includes additional components such as 159 
pain motivation; to quantify said motivation; self-reported desires to avoid pain were 160 
measured.  CPM represents one type of central pain process; that of descending spinal 161 
modulation, that although not currently tested in ASD populations, is a paradigm easily 162 
implemented in a laboratory setting.  It is a process whereby one noxious stimulus inhibits the 163 
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perception of a second noxious stimulus, where greater reductions in pain are thought to 164 
reflect greater pain inhibitory capacity (Martel, Wasan, & Edwards, 2013; Nir & Yarnitsky, 165 
2015).  The addition of each will give insight into tolerance, pain motivation, and central pain 166 
processes in ASD.   167 
Methods 168 
Participants 169 
Twenty-six adults (14 males) covering an age range between 18 and 52 years were 170 
recruited (M = 27.15, SD = 8.50) to this case-control study.  ASD participants were recruited 171 
from a specialist diagnostic service within a local hospital trust and had received a diagnosis 172 
based on the DISCO (Diagnostic Interview for Social and Communication Disorders) and/or 173 
ADOS (Autism Diagnostic Observation Schedule) from a trained clinician.  Diagnosis letters 174 
were obtained from participants where possible, which confirmed diagnosis and IQ values 175 
>70.  Those suffering from chronic pain, eczema, epilepsy or asthma were excluded.  176 
Additionally, any with a reported history of a psychiatric disorder or learning disability were 177 
excluded.  Thus, 13 ASD participants were included in the study; there were seven males and 178 
six females with a mean age of 27.22 years (SD = 9.19).  No participant reported any 179 
medication use for depression or anxiety, although one reported the use of Amlodipine (for 180 
angina) and one reported the use of Lansoprazole (for ulcers).  181 
Thirteen control participants without a diagnosis of ASD were recruited through 182 
advertisement, selected to match each autistic individual on age (M = 27.08, SD = 8.129) and 183 
gender (7 males).  All were subject to the same exclusion/inclusion criteria above.  Although 184 
not explicitly matched on IQ, the control group were from the general population, suggesting 185 
IQ>70.  All participants in both groups were without pain medication or alcohol at least 24 186 
hours before the investigation. 187 
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As groups (n=13 per group) were age and gender matched they did not significantly 188 
differ; t(22) = -.045, p = .964 and χ²(1) = 0, p = .652, respectively.  As expected groups had 189 
significantly different AQ score (Autism Quotient: (Baron-Cohen, Wheelwright, Skinner, 190 
Martin, & Clubley, 2001) scores, t(24) = -6.003, p = .000, with the ASD group scoring higher 191 
(see table 1 below for descriptive statistics). 192 
[Table 1] 193 
The study was approved by Liverpool John Moores Ethics Committee (REC ref: 194 
15/NSP/023) and NHS Health Research Authority ethics committee (Ref: 16/EM/0402) and 195 
all participants gave written informed consent. 196 
Procedure and design 197 
To quantify self-reported autistic trait severity participants completed the AQ (Baron-198 
Cohen et al., 2001).  QST was performed first.  This standardized battery provides a sensory 199 
profile that consists of 13 parameters (see table 2 below, Rolke et al. (2006) and 200 
supplementary methods for full description).  Additional cold pressor and CPM tests were 201 
added to the battery and all tests were performed in the same order, using the same set of 202 
standardised instructions and performed on the same site on each participant. 203 
[Table 2] 204 
Cold pressor test 205 
A custom cold pressor (Dancer Design), which maintains water in a stimulus tank at a 206 
predefined temperature (2°C), measure both cold pain tolerance and threshold.  A control unit 207 
containing a temperature controller drives water taken from a reservoir of ice water 208 
(maintained at 0°C) through the stimulus tank at a controlled rate, therefore, maintaining the 209 
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requested temperature within 0.10°C (see appendices for full description and schematic 210 
diagram). 211 
Pain threshold is defined as the elapsed time between arm immersion and the first 212 
report of a pain sensation. Pain tolerance is defined as the elapsed time until the hand is 213 
voluntarily removed.  Since the Cold Pressor test induces pronounced sympathetic activation 214 
and vasoconstriction, the maximum duration of limb immersion was set at 3 minutes 215 
(Mitchell, MacDonald, & Brodie, 2004). 216 
Conditioned pain modulation (CPM) 217 
To assess CPM baseline pressure pain thresholds (PPT) was firstly performed on the 218 
right upper trapezius, approximately 2 cm from the acromioclavicular joint with a handheld 219 
pressure algometer (Somedic) with a 1cm2 probe area.  The threshold was determined with an 220 
ascending stimulus intensity, applied as a slowly increasing ramp of 50kPa/s until 221 
participants report a painful sensation.  Immediately following the assessment of PPT, 222 
participants underwent a cold pressor test, immersing their hand up to the wrist in a stimulus 223 
tank of 2°C water.  Twenty seconds following hand immersion, PPT was re-assessed on the 224 
right trapezius (i.e. the same site as baseline assessment).     225 
Avoidance and motivation scores for pinprick stimuli including stimulus/response function 226 
(MPS/DMA) 227 
Pain experience is more than just the sensory experience, the functional purpose of 228 
pain is to create a motivational state to avoid future harm (Eccleston & Crombez, 1999).  To 229 
measure the motivation to avoid experiencing painful stimuli, participants were asked that, 230 
for every stimulus that was given a pain rating (a value above 0 on a numeric rating scale of 0 231 
– 100 where 0 means no pain and 100 means the most intense pain imaginable: see the QST 232 
supplementary materials for MPS, DMA and WUR) during Mechanical Pain Sensation 233 
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(MPS), Dynamic Mechanical Allodynia (DMA) and Wind-Up Ratio (WUR), to rate how 234 
much they would like to avoid feeling that stimulus.  Avoidance was rated using the same 235 
scale as the aforementioned QST parameters of 0 to 100; 100 being “would never like to 236 
experience the stimulus again”.  MPS avoidance was calculated as the geometric mean of all 237 
avoidance ratings for pinprick stimuli, while DMA avoidance was the geometric mean of all 238 
avoidance ratings corresponding to the dynamic stimuli.  The wind-up ratio avoidance was 239 
calculated as the ratio of the mean of the five series avoidance ratings divided by the mean of 240 
the five single stimuli avoidance ratings.   241 
Data preparation 242 
QST 243 
Preparation of individual participants data followed the guidance of the DNFS (Rolke 244 
et al. (2006).  For pinprick (MPS/DMA), as well as their corresponding avoidance measures, 245 
a small constant (+0.1) was added prior to log-transformation to avoid a loss of zero rating 246 
values (Bartlett, 1947; Magerl, Wilk, & Treede, 1998).  247 
For each individuals raw scores it has been previously established that all QST data 248 
except Paradoxical Heat Sensations (PHS), Cold Pain Threshold (CPT), Heat Pain Threshold 249 
(HPT), and Vibration Detection Threshold (VDT) follow either a logarithmic progression 250 
(i.e. stimulus intensity of the pin prick stimuli are 8mN, 16mN, 32mN, …) or that these data 251 
always conform to this distribution, therefore individual participants raw scores were 252 
logarithmically transformed before creation of mean values for analysis (Magerl et al., 2010; 253 
Rolke et al., 2006).  To permit normalisation for age, gender and testing site, each 254 
individual’s QST data were z-transformed by subtracting the mean value of the 255 
corresponding published QST reference value followed by a division by the respective 256 
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standard deviation from the normative database for the appropriate age and gender group; for 257 
each QST parameter using the following expression: 258 
Z-score = (Xsingle participant – Meannorms)/SDnorms; 259 
An additional reason for this transformation is that it results in a QST profile where 260 
all parameters are presented as standard normal distributions.  For clarity and ease, in order to 261 
think in terms of gain (lower thresholds or lower intensity stimulus required for detection or 262 
pain report) or loss of function (higher thresholds, or greater intensity required for detection 263 
or pain report), the algebraic sign of Z-score values was adjusted so that it would reflect a 264 
participant’s sensitivity to this parameter.  Z-values above “0” indicate a gain of function, 265 
when the patient is more sensitive to the tested stimuli, while a score below “0” indicate a 266 
loss of function referring to a lower sensitivity.  Thus all required reversing, with the 267 
exception of CPT, MPS, DMA and WUR.  For PHS and DMA it is a priori impossible to 268 
assess a pathological reduction since these signs are normally absent in a healthy population.  269 
If the resulting Z score exceeds 1.96, it is outside the 95% confidence interval of the standard 270 
normal distribution with zero mean and unit variance, independent of the original units of 271 
measurement.  An advantage beyond that of establishing whether any participant, 272 
neurotypical or ASD has clinically significant sensory loss or gain (which also allows us to 273 
check that our control group can indeed be that), is of the utility of this method so allow us to 274 
map individuals QST patterns.  This somewhat allows us to navigate the ASD phenotype and 275 
look at individual level data. 276 
QST data were re-transformed and raw values are presented in table 3 as mean ± SD 277 
to ease understanding, and so that data could be presented in terms of the individual units of 278 
measurement e.g. temperature in ˚C.  All inferential statistics for QST were conducted on z-279 
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scored data.  Where values are presented as z-scores figures and tables state this. All 280 
statistical calculations were performed with SPSS.   281 
Additional sensory tests 282 
 These data did not undergo the same transformation as the QST data.  This was to 283 
ensure that results were comparable to other published data where possible. 284 
Results 285 
It was possible to obtain all QST data in all 26 participants.  For one-control 286 
participant WUR, avoidance scores could not be calculated because the denominator (mean 287 
rating for the single stimulus) was zero. 288 
QST reference data between groups 289 
[Figure 1] 290 
Group comparisons of each QST parameter’s mean Z score, using independent t-tests, 291 
revealed a significant difference for mechanical detection and pain threshold (MDT & MPT).  292 
The ASD group (M = 8.238mN) required a significantly greater force to detect light touch 293 
than the control group (M = 3.267), t(24) = -3.073, p = .005.  They also reported pain at a 294 
greater force (M = 125.596mN) for mechanical pain than controls (M = 46.687mN) t(24) = -295 
2.950, p = .007.  The ASD group shows hyposensitivity to mechanical stimuli compared to 296 
controls; although only in the case of MDT does this reflect hypoesthesia for mechanical 297 
detection (as shown by a value that falls outside the 95% confidence interval of the published 298 
reference data). 299 
[Table 3] 300 
Additional sensory tests 301 
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Cold Pressor Test 302 
Independent t-tests revealed there were no significant group differences for cold 303 
presser threshold or tolerance, t(24) = -.291, p = .773 and t(24) = -.667, p = .511, respectively 304 
(see table 3 for mean values).   305 
Conditioned Pain Modulation 306 
A repeated measures ANOVA revealed that pressure pain was significantly 307 
modulated by a cold pressor test F(1) = 12.793, p = .002, r = 0.6, as the pressure pain 308 
threshold increased after the hand was submerged for the 20s, across groups, supporting the 309 
existence of a CPM effect in the sample.  The magnitude of this CPM effect, however, did 310 
not significantly differ between groups, F(1) = 1.974, p =.173, r = 0.2 (see figure 2).  Cold 311 
pressor pain mediated pressure pain, as shown by the increase in pressure required to elicit a 312 
pain response regardless of group (see table 3 for mean values and figure 2 for illustration). 313 
[Figure 2] 314 
Avoidance scores for pinprick stimuli including stimulus/response function 315 
(MPS/DMA) 316 
For avoidance scores, t-tests were only conducted when parametric assumptions were 317 
met; otherwise, Mann-Whitney U test was used.  There were no group differences for MPS 318 
avoidance (t(24) = -.260, p = .797).  Neither, DMA nor WUR avoidance differed between 319 
groups (U =68.000, z = -.879, p = .194 and U =66.000, z = -.958, p =.178).   320 
QST profiles of z-transformed data in individual participants 321 
[Figure 3] 322 
Overall, there were a greater number of z-scores (see figure 3) that fell outside of the 323 
95% confidence levels within the total sample than would be expected by chance (n = 48, 324 
15 
 
allocated to 19 individuals).  For a sample of this size, with 13 QST parameters, 95% 325 
confidence interval (CI) levels estimate that 15 values would that lie outside the 95% CI level 326 
of the DFNS reference data.  This variance is driven by the larger number of abnormal z-327 
scores in the ASD group (n = 32 allocated to all 13 individuals) compared to controls (n = 16 328 
allocated to 6 individuals); who show typical numbers of outlying scores.    329 
Intra-individually, 95% CI dictates that one z-score in the 13 QST parameters would 330 
potentially be outside this level, which suggests that only 15 of our participants are showing 331 
atypical QST patterns (where the number of z-scores outside the 95% CI >=2).  A greater 332 
number of ASD individuals were found to have extreme scores compared to controls, and the 333 
range of these scores was wider in ASD individuals (2-5) compared to controls (2-3).  334 
However, the average number of these scores per participant, in those that showed this 335 
atypical pattern, was similar between the groups (see table 4 below for descriptive statistics).  336 
Therefore, although a greater percentage of individuals with ASD may show atypical patterns 337 
of pain response, when considering these altered responses they may be within a range seen 338 
in a similar neurotypical group. 339 
[Table 4] 340 
Furthermore, 1 autistic individual showed sensory distinctive features in the form of 341 
PHS; experiencing a warm, hot or painfully hot sensation in response to the cold stimulation, 342 
that usually does not occur in healthy subjects and two felt allodynia to non-painful stimuli 343 
(DMA).  These observations suggest that in this small population of individuals with ASD 344 
that there are notable changes in peripheral function.  Although these features do not appear 345 
to be typical of ASD, this does suggest sub-groups of ASD in which altered somatosensory 346 
processing may be present.  Further, it appears that differences in sensory processing in some 347 
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individuals may not simply be in terms of magnitude of response.  Rather, it might reflect the 348 
presence of phenomena not typically seen in neurotypical individuals.   349 
Discussion 350 
The current study investigated somatosensory perception in autistic individuals to test 351 
the hypothesis that the different pain behaviours observed in anecdotal accounts were the 352 
result of an alteration in somatosensory mechanisms.  For this reason, and to allow the 353 
comparison to published norms, 13 autistic adults and 13 age- and gender- matched control 354 
participants without autism, underwent a standardised and normed QST protocol (DFNS: 355 
Rolke et al., 2006).  No observable consistent pathological QST pattern suggesting a defined 356 
nerve fibre dysfunction, which could account for the altered pain behaviours observed, was 357 
found.  The ASD group showed no systematic changes in their QST pattern.   358 
Group differences were found, however, for both mechanical pain threshold (MPT; 359 
pinprick stimuli) and mechanical detection threshold (MDT; von Frey filaments), with the 360 
ASD group showing higher thresholds for both.  Although the ASD group had higher 361 
thresholds compared to the control group, data for both groups reside within the normal 362 
distribution of healthy individuals, as established by the DFNS, indicating that although the 363 
ASD group may be less sensitive to mechanical pain than controls this sensitivity is not 364 
clinically significant.  However, ASD group mean value for MDT fell outside the normative 365 
range for healthy individuals, suggesting a clinically significant degree of sensory loss at the 366 
group level.  Normal z scores for other clinically related QST parameters – such as vibration 367 
detection threshold – do suggest, however, typical Aβ-fibre function (Grone et al., 2012). 368 
Vibrotactile and punctate stimulation are both communicated via Aβ-fibres, though 369 
detected by different receptor pathways, which may account for the aforementioned 370 
differences.  High frequency vibration is detected via rapidly adapting Pacinian corpuscle and 371 
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generally have a large receptive field.  Mechanical stimulation, on the other hand, are 372 
detected via slowly adapting Merkel cell-neurite complex receptors and is tactile detection 373 
via indentation depth (Delmas et al., 2011).  Different Aβ-fibre phenotypic alterations may 374 
therefore be present and be stimuli specific, due to detection of such stimuli by their specific 375 
receptors.  Such differences are highlighted in the evidence when contrary to the sensory loss 376 
of MDT measured by von Frey, increased sensitivity to vibration is reported (Cascio et al., 377 
2008).  There is greater difficulty in comparing vibration results in the literature, due to the 378 
varied vibration frequencies used (Blakemore et al., 2006; Guclu et al., 2007), yielding very 379 
different results which may similarly be a result of different receptor activation (Lumpkin, 380 
Marshall, & Nelson, 2010; McGlone & Reilly, 2010; McGlone, Wessberg, & Olausson, 381 
2014).  It must also be noted that the use of a tuning fork for vibrotactile assessment is 382 
sensitive enough to identify neuropathy – as intended – however, may not be sensitive 383 
enough to measure more subtle changes in threshold.  Findings for MDT are in line with 384 
Fründt et al. (2017) who similarly report a significant loss of function for mechanical 385 
detection in ASD participants using the same standardised testing from the QST battery.       386 
Similar to Fründt et al. (2017) who report PHS and DMA in two autistic individuals 387 
(see also Duerden et al., 2015), three participants showed distinctive sensory features in the 388 
form of paradoxical heat sensations (n=1; PHS) and dynamic mechanical allodynia (n=2; 389 
DMA), that do not usually occur in healthy individuals or the control group on the upper 390 
limbs.  Given that the different QST parameters did not reveal any specific signs of nerve 391 
fibre dysfunction in both studies, we concur with the author’s suggestion that central 392 
mechanisms determine PHS in the ASD groups.  Studies of patients with CNS demyelination 393 
confirm central processing issues that result in PHS (Hansen, Hopf, & Treede, 1996).  394 
Limited research has attempted to understand the central processing of pain in ASD using 395 
neuroimaging techniques.  This research supports the idea that changes in pain processing in 396 
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ASD is complex: suggesting that there is an initial processing which is similar to controls, 397 
however, there is a reduction in neural activity during sustained pain that is not present in 398 
controls (Failla et al., 2017).  This gives further support to the need to be flexible about how 399 
pain experience is considered in ASD. 400 
A further phenomenon, observed by this study and that of Fründt et al. (2017) is that 401 
of DMA.  Both studies are the first to experimentally measure DMA in ASD, observing this 402 
in a subset of the ASD groups.  DMA is the experience of perceiving innocuous touch, such 403 
as gentle stroking, as aversive, a phenomenon described in ASD sensory over-responsivity 404 
literature (Baranek & Berkson, 1994; Green et al., 2015; Reynolds & Lane, 2008).  Central 405 
sensitisation i.e. changes in signalling in the spinal cord (Campbell & Meyer, 2006), is 406 
commonly thought to underlie DMA (Gierthmühlen et al., 2012), as it is the increased 407 
response of neurons to stroking stimuli.  Intriguingly, some groups have offered a peripheral 408 
explanation for DMA (Liljencrantz et al., 2013), whereby an alteration in C-tactile afferent 409 
function, which typically mediates a pleasant percept associated with low force slow stroking 410 
touch, communicates noxious experience. This explanation then lends weight to research 411 
suggesting that an early mechanism behind ASD may be an alteration in CT fibre function 412 
(Cascio, Moore, & McGlone, 2018; Gordon et al., 2013; Kaiser et al., 2016; Walker & 413 
McGlone, 2013).  It is clear that this proposition requires further investigation.  However, 414 
QST cannot fully distinguish between central and peripheral alterations (Mücke et al., 2014), 415 
therefore we can only speculate at this time.  416 
There are striking similarities between our findings and those of Fründt et al. (2017).  417 
Both were independently conducted, in parallel, and sought to use the DFNS QST protocol to 418 
identify differences that might exists in somatosensory function is ASD.  Both studies found 419 
little evidence for a diagnosis-wide change in either somatosensory detection or pain 420 
thresholds.  Both also found that when Z-scores were compared to published norms that more 421 
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autistic individuals showed a-typical data points, suggesting that individual differences may 422 
be of importance.  This replication is particularly powerful as psychological sciences wrestle 423 
with the reproducibility crisis (Aarts et al., 2015).  Here, independent verification of findings 424 
has been achieved, to provide a platform upon which to build future research. 425 
An advantage of the standardised QST method is the published normative data which 426 
provides clear definitions of sensory loss and gain.  The ASD phenotype can drastically differ 427 
and has large individual differences meaning the typical group analyses may not be 428 
advantageous to understanding this spectrum condition.  Such published norms, which an 429 
individual’s QST pattern can be compared to, provides the opportunity to quantify individual 430 
cases.  Individual analyses revealed a greater inter-individual variance with more Z-scores 431 
outside the 95% confidence interval of the DFNS published normative values in the ASD 432 
group (n=32).  This variance was present in all QST parameters and was not driven by a 433 
single participant (n=13 participants).  This might reflect the general heterogeneity of the 434 
ASD group; such heterogeneity belies the attempt to group this population under one 435 
diagnostic umbrella.  The utility of this type of analysis is best shown in figure 3, which 436 
illustrates the sensory profiles of autistic individuals, and their sensory changes (see results 437 
section).  This also allows individual differences in the phenotypic presentation of ASD to be 438 
considered alongside their QST pattern. 439 
In order to gain a self-report measure of motivation for pain avoidance, individuals 440 
were asked: “how much would they like to avoid feeling the stimulus again?”.  However, 441 
these results were inconclusive.  Self-report measures of pain motivation do not appear 442 
therefore, to access motivation in a way that provides a clearer or deeper understanding.  For 443 
this reason, elegant experimental paradigms that have been used in healthy populations for 444 
understanding goal attenuation of avoidance behaviour could be adopted and utilised in an 445 
ASD population (Claes, Crombez, & Vlaeyen, 2015; Claes, Karos, Meulders, Crombez, & 446 
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Vlaeyen, 2014; Meulders & Vlaeyen, 2012, 2013).  Such experiments can implicitly test 447 
motivation that goes beyond conscious self-reporting by measuring behavioural responses 448 
and understanding avoidance in the context of multiple goals.  This could be of vital 449 
importance in a population driven to achieve their repetitive or restrictive behaviour patterns 450 
regardless of other incoming behaviourally motivational stimuli, such as pain.  Furthermore, 451 
given that the QST battery revealed typical nerve fibre function and that CPM appeared 452 
typical, this approach may help to pull apart the altered pain behaviours by considering top 453 
down modulation of pain.   454 
Given the nature of sensory testing- applying a stimulus and recording verbally the 455 
perception of that stimulus, the underlying mechanisms can only be judiciously speculated 456 
upon.  The pain experience in such studies is delivered in controlled environments, devoid of 457 
motivational context or other environmental cues.  This absence of environmental context, 458 
results in a lack of knowledge about how distraction and other psychological effects might 459 
affect pain perception in ASD or how they modulate the more simple sensory experience of 460 
an input.  It is also understandable, brief and cutaneous in nature, which may not reflect the 461 
diversity of pain in the real world (the relative merits and challenges of QST measures have 462 
been considered extensively elsewhere e.g. Backonja et al., 2013; Rolke et al., 2006).  By 463 
comparison, naturally occurring pain is frequently endogenous, of longer duration, can be 464 
diffuse, and typically involves multiple pain systems.  Further, ethical standards of pain 465 
induction that mitigate the threat of pain, fundamentally altering the emotional and 466 
motivational significance of pain is arguably a key feature of pain that emerges naturally 467 
(Edens & Gil, 1995).  The cost of such control is the potential lack of relevance to naturally 468 
occurring pain (Robertson & Low, 2006; Rollman, 2005).  The methodological challenge is 469 
to develop techniques that combine the benefits of laboratory control with the relevance of 470 
pain that emerges naturally (Moore, Keogh, Crombez, & Eccleston, 2013).   471 
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The findings of the present study should be considered in light of several limitations; 472 
notably the small sample size, which is common in the literature (Cascio et al., 2008; 473 
Duerden et al., 2015; Fründt et al., 2017; Guclu et al., 2007).  Many autistic individuals find 474 
novel environments distressing and therefore may be unlikely to participate.  Additionally, 475 
fear of pain and anxiety may likely reduce participation in experimental pain research (Karos, 476 
Alleva, & Peters, 2018).  This paired with an exclusion of those with anxiety and depression, 477 
placed further limitations on recruitment numbers.  This control, however, gives added 478 
validity to the results, as these conditions are known to have effects on pain perception (for 479 
review see Goesling, Clauw, & Hassett, 2013; Thompson, Correll, Gallop, Vancampfort, & 480 
Stubbs, 2016).  Future studies should adopt this singular diagnosis approach and increase 481 
sample size, regardless of the difficulties caused by frequent psychiatric comorbidities in this 482 
population (Joshi et al., 2013).  A related limitation is the inability to examine the effect of 483 
individual differences on pain responses, specifically IQ.  Although participants had been 484 
formally assessed for a diagnosis of ASD and had been assessed for IQ in the normal range 485 
by a trained clinician, it was not possible to obtain detailed psychometrics.  Further 486 
independent testing of IQ within the study, was deemed to be burdensome and in the interests 487 
of the well-being of the participant was excluded from the protocol.  Additionally the 488 
addition of an IQ test to an already extensive protocol may have increased stress and 489 
therefore resulted in an unrepresentative response to stimuli.  It would be beneficial in future 490 
studies to find mechanisms to understand key individual differences which might affect pain 491 
response in ASD.  IQ in particular may be an important factor to consider as it has been 492 
shown that thermal pain response may be correlated with IQ, with participant’s with a lower 493 
IQ score having higher thresholds (Duerden et al., 2015).  It was not possible to test this 494 
finding in the current research. 495 
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In conclusion, there was no systematic alteration to suggest an underlying dysfunction 496 
in the cutaneous somatosensory modalities tested in this study.  There was a larger number of 497 
outlying z-score values within the ASD group.  Further, dynamic mechanical allodynia and 498 
paradoxical heat sensations were present in some ASD participants, which is typically only 499 
observed in patients with peripheral neuropathy.  Central processing and integration of 500 
sensory information rather than peripheral perception seems to be a better candidate for 501 
further research within ASD.  In order to test this theory, future studies should focus on 502 
combining QST measurements with neuroimaging to detect probable processing differences.  503 
Additionally, studies could use experimental paradigms that test pain motivation to assess 504 
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Table 1: Characteristics and questionnaire results of ASD and control group. 716 
Characteristic  ASD Controls Total 
No. of participants 13 13 26 
No. of participants with:  ASC 
   HF autism 



















Autism Quotient (AQ) 32.00 ± SD 6.58 15.38 ± SD 7.50 23.69 ± SD 10.94 
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Table 2: Details of Standardised Quantitative Sensory Testing battery, tests and associated 740 
peripheral sensory channel 741 
Group 
No. 
Description Test (Abbreviation) Peripheral sensory 
channel 
    
1. Thermal detection thresholds for the 
perception of cold, warm and paradoxical 
heat sensations. 
Performed using a Medoc Pathway 
stimulator, ramped stimuli 1°C/s, baseline 
temperature 32°C and a 9cm² Thermode. 
Cold detection threshold (CDT) 
Warm detection threshold (WDT) 
Paradoxical heat sensations (PHS) 





2. Thermal pain thresholds for cold and hot 
stimuli (as above). 
Cold pain threshold (CPT) 
Heat pain threshold (HPT) 
C, A-delta 
C, A-delta 
3. Mechanical detection thresholds for touch 
and vibration. 
Performed using a modified set of von Frey 
hairs (0.25 to 512mN) with 5 ascending and 5 
descending stimulus intensities and a 64Hz 
tuning fork (8/8). 
Mechanical detection threshold (MDT) 
Vibration detection threshold (VDT) 
A-beta 
A-beta 
4. Mechanical pain sensitivity, including 
thresholds for pinprick, stimulus-response 
functions for pinprick sensitivity, dynamic 
mechanical allodynia and pain summation to 
repetitive pinprick stimuli. 
Performed using a set of weighted pin-pricks 
that exert forces of 8, 16, 32, 64, 128, 256 
and 512mN. 
Mechanical pain threshold (MPT) 
Mechanical pain sensitivity (MPS) 
Dynamic mechanical allodynia (DMA) 





5. Pressure pain threshold.  
Performed using an algometer with a 1cm² 
probe area, where stimulus intensity is 
gradually increased at a ramp rate of 50kPa.s. 
Pressure pain threshold (PPT) C, A-delta 
6. Cold pain threshold and tolerance. 
Performed with a custom cold pressor which 
maintains water at 2°C, participants 
submerge their dominant hand in the water 
stating “pain” for threshold and tolerance is 
measured as the point at which the hand is 
voluntarily removed. 
Cold pressor test C, A-delta 
7. Pain modulation. 
Performed using an algometer with a 1cm²-
probe area, where stimulus intensity is 
gradually increased at a ramp rate of 50kPa/s 
and a cold pressor test (see 6.) 
Conditioned Pain Modulation (CPM)* - 
Test order: Cold and warm thermal detection thresholds are acquired first followed by paradoxical heat sensations 
during thermal sensory lumen of alternating warm and cold stimuli (no.1).  Cold and heat thermal pain thresholds 
(no.2) are then determined.  Then follows; mechanical detection (no.3), mechanical pain (no.4), stimulus/response 
functions with dynamic mechanical allodynia (no.4), wind-up ratio (no.4), vibration (no.3), pressure pain (no.5), 
cold pressor test (no.6) and lastly conditioned pain modulation (no.7) is performed.  
Darker grey shaded boxes show additional tests that are not part of the DFNS QST battery (i.e. no. 6 & 7). 
*This is a measure of central pain processes not of the peripheral sensory channels; although these channels are 
involved in the initial detection of the relevant stimuli (see no. 4 and 5). 
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Table 3: Untransformed data values of QST test parameters given for each group. 744 
Parameter (Mean ± 
Standard Deviation) 
ASD Controls p value Effect size 
QST parameter     
 CDT (˚C) 30.423 ± SD .661 30.503 ± SD 1.019 .579  = 0.2 
 WDT (˚C) 34.618 ± SD 1.545 34.092 ± SD .758 .287  = 0.5 
 TSL (˚C) 5.103 ± SD 2.415 4.550 ± SD 1.951 .515  = 0.2 
 PHS (n) 0.150 ± SD 0.555 . .317  = 0.1 
 CPT (˚C) 20.615 ± SD 6.651 16.546 ± SD 12.021 .491  = 0.3 
 HPT (˚C) 42.297 ± SD 3.576 40.918 ± SD 2.598 .272  = 0.4 
 MDT (mN)+* 8.238 ± SD 7.638 3.267 ± SD 2.564 .005  = 1.2 
 MPT (mN)+* 125.296 ± SD 157.378 46.687 ± SD 37.438 .007  = 1.2 
 MPS (PR)+ 1.860 ± SD 2.382 2.048 ± SD 2.570 .685  = 0.2 
 DMA (PR)+ .863± SD 2.698 . .379  = 0.4 
 WUR (PR)+ 5.498 ± SD 7.533 2.021 ± SD 2.369 .203  = 0.5 
 VDT (/8) 7.282 ± SD .880 7.744 ± SD .512 .129  = 0.8 
 PPT (kPa)+ 307.205 ± SD 60.124 361.846 ± SD 105.572 .162  = 0.6 
Additional Sensory Tests 
(Mean ± Standard 
Deviation) 
    
 CP threshold (s) 12.245 ± SD 7.901 11.284 ± SD 8.891 .773  = 0.1 
 CP tolerance (s) 37.278 ± SD 45.493 28.235 ± SD 17.873 .511  = 0.3 
 CPM1 (kPa) 317.770 ± SD 111.456 345.000 ± SD 95.076 .173 See results 
 CPM2 (kPa) 428.920 ± SD 202.720 393.46 ± SD 123.799 .173 See results  
Note: Group raw data values for each QST parameter and additional sensory tests given as mean ± SD to aid understanding in terms of their actual unit of measurement i.e. 745 
temperature in Celsius. 746 
All p values and effect sizes given for QST parameters are for the inferential statistics conducted on transformed data as discussed in the methods section. 747 
+values are presented as geometric means. 748 
*p<.05. 749 
 Non-parametric Mann-Whitney U conducted for these parameters as they did not meet assumptions, all other parameters met parametric assumptions and therefore 750 
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Table 4: Number of participants with atypical QST patterns and the mean number of 765 
abnormal z-scores of each participant. 766 
 ASD Controls Total  
No. of participants 10 5 15 
Abnormal z-scores 2.9 ± SD 1.101 2.8 ± SD 1.366 2.867 ± SD 1.325 
Range of abnormal z-scores 2-5 2-3 2-5 
Note: Total number of participants in each group showing abnormal values (where the number of abnormal values >=2; i.e. are outside the 95% CI of the reference data).   767 
The number of abnormal values per individual in the groups is given as a mean ± SD, and range. 768 
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Figure Captions 771 
Figure 1.  Adjusted Z-score data for ASD vs. control group, across all 13 QST parameters 772 
including standard error bars. * indicates significant group differences.  Any column that 773 
extends outside the 95% confidence interval of the normal distribution of healthy subjects 774 
(=area between the black lines) signifies sensory changes. 775 
Figure 2.  Group data for conditioned pain modulation, including standard error bars, given 776 
as raw data values. * indicates significant stimulus time-point differences.   777 
Figure 3.  Individual results of QST parameters given as Z-scores of autism participants (red) 778 
vs. controls (blue).  Any marker that extends outside the 95% confidence interval of the 779 
normal distribution of healthy subjects (=area between the black lines) signifies sensory 780 
changes.  Values that extended beyond 4 standard deviations were given a maximum value of 781 
3.999 or -3.999 and true values are given next to the marker.  Data were constrained in this 782 
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